OKYO Pharma Limited

NASDAQ: OKYO · Real-Time Price · USD
2.61
-0.03 (-1.14%)
At close: Aug 15, 2025, 1:24 PM

OKYO Pharma Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
-7.97M -16.83M -13.28M -6.22M -3.38M
Depreciation & Amortization
2.56K 3.87K 3.8K 2.33K 13.11K
Stock-Based Compensation
734.99K 1.12M 1.27M 1.72M 544.39K
Other Working Capital
410.21K -570.08K 982.04K -753.25K 1.05M
Other Non-Cash Items
3.79M 3.54M 114.99K 61.72K 83K
Deferred Income Tax
n/a n/a 250.34K -9.41K 92.95K
Change in Working Capital
1.63M 2.67M 3.95M -1.02M 1.04M
Operating Cash Flow
-1.81M -9.49M -7.7M -5.47M -1.6M
Capital Expenditures
-1.21K -3 -5.92K -1.67K -6.94K
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -11.15K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -11.17K
Investing Cash Flow
-1.21K n/a -5.92K -1.67K -18.11K
Debt Repayment
950K n/a 2M n/a 7.58M
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 2.15M 15.87K
Financial Cash Flow
2.66M 6.21M 9.32M 2.15M 7.83M
Net Cash Flow
734.05K -3.22M 1.34M -4.19M 6.65M
Free Cash Flow
-1.81M -9.49M -7.7M -5.47M -1.61M